Company Filing History:
2 out of 5,094 
2 out of 2 
2 out of 7 Years Active: 2008-2011
Title: Melitta Schachner: Innovator in Neurodegenerative Disease Research
Introduction
Melitta Schachner is a prominent inventor based in Hamburg, Germany. She has made significant contributions to the field of neurodegenerative diseases through her innovative research and patented inventions. With a total of 2 patents, her work focuses on the modulation of neural cell adhesion molecule (NCAM) functions, which has implications for treating various neurological conditions.
Latest Patents
Melitta Schachner's latest patents include the use of poly-α2,8-sialic acid mimetic peptides to modulate NCAM functions. The first patent describes a peptide consisting of 5 to 30 amino acid residues, preferably 9 to 15, most preferably about 12 amino acid residues. This peptide comprises a B epitope of a poly-α2,8 sialic acid attached to NCAM, recognized by an anti-poly-α2,8 sialic acid (PSA) antibody. The invention aims to prepare a medicament for modulating NCAM functions, which can be administered for the prevention and treatment of neurodegenerative diseases, brain and spine lesions, age-related learning and memory problems, and cancer. The second patent reiterates similar findings and applications, emphasizing the importance of these peptides in medical treatments.
Career Highlights
Throughout her career, Melitta Schachner has worked with esteemed organizations such as the Centre National De La Recherche Scientifique and Schafer-n. Her research has been pivotal in advancing our understanding of neurodegenerative diseases and developing potential therapeutic strategies.
Collaborations
Some of her notable collaborators include Pascal Torregrossa and Claus Schafer Nielsen. Their combined expertise has contributed to the success of her research endeavors.
Conclusion
Melitta Schachner's innovative work in the field of neurodegenerative diseases highlights her role as a leading inventor. Her patents and research continue to pave the way for new treatments and understanding of complex neurological conditions.